Tesofensine vs Dulaglutide

Head-to-head comparison of Tesofensine (Tesofensine (NS2330)) and Dulaglutide (Recombinant GLP-1 receptor agonist Fc fusion protein) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyTesofensineDulaglutide
CategoryWeight ManagementWeight Management
Full NameTesofensine (NS2330)Recombinant GLP-1 receptor agonist Fc fusion protein
Molecular Weight426.52 g/mol~63,000 Da
Half-Life~200-300 hoursAbout 5 days
Amino AcidsSmall moleculeN/A
Typical Dose0.75-4.5 mg weekly
RouteSubcutaneous
Purity>98%≥98%
Studies Count35700
Research StatusPhase III Clinical TrialsApproved

Tesofensine Benefits

  • Potent appetite suppression, increased metabolic rate, enhanced thermogenesis, improved mood during dieting, reduces food reward-seeking behavior

Dulaglutide Benefits

  • modest weight loss
  • lower A1c
  • weekly dosing convenience
  • cardiometabolic benefit

Tesofensine Dosing

Clinical doses: 0.25-1.0 mg orally once daily. Research typically uses 0.5 mg. Extremely long half-life (8-13 days) means steady-state in 7-10 days.

Dulaglutide Dosing

0.75-4.5 mg SC weekly|Increase based on response and tolerance|Administer on the same day each week

Tesofensine Side Effects

  • Dry mouth, insomnia, constipation, increased heart rate, elevated blood pressure. Not recommended with uncontrolled hypertension.

Dulaglutide Side Effects

  • nausea
  • diarrhea
  • injection-site reactions

Research Overview

Tesofensine

Phase II trials showed 12.8 kg average weight loss at 1.0 mg dose over 6 months. Simultaneously inhibits reuptake of norepinephrine, dopamine, and serotonin, producing appetite suppression and increased thermogenesis.

Dulaglutide

Dulaglutide has repeatedly shown small-to-moderate reductions in body weight alongside glycemic improvement in large diabetes trials. It is a useful comparator for GLP-1 receptor agonist effects on appetite and weight.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Tesofensine stacks with:

5-Amino-1MQAOD-9604MOTS-c

Dulaglutide stacks with:

metformindiet-and-exercise
weight-lossappetite-suppressanttriple-reuptake-inhibitorthermogenesisGLP-1RAweekly-injectiontype-2-diabetesmodest-weight-loss